The Effect of Adjuvant Therapy on Metabolic Syndrome in Schizophrenia Patients at Madani Hospital
Abstract
Background: Schizophrenia is a mental disorder that impacts behavior, emotions, and communication. In recent years, atypical antipsychotics have been increasingly prescribed because they significantly reduce both positive and negative symptoms. However, the long-term effects of atypical can cause metabolic syndrome. Additional therapy is provided to maximize the primary therapy and reduce the side effects.
Method: This study used a quasi-experimental design with a single-blind, pretest-posttest approach. Patients who had been using atypical antipsychotics, either monotherapy or combination therapy, for more than 3 were examined pretest to determine metabolic syndrome levels. Group A received adjuvant therapy, while Group B did not receive adjuvant therapy. Based on this data, an analysis of the reduction in metabolic syndrome categories was conducted.
Result: The percentage of schizophrenia patients by gender was dominated by males (60%). By age, the majority were adults (87%). In Group A, the incidence of metabolic syndrome decreased from 53% in the pretest to 40% in the posttest after being given vitamin A, B, and folic acid therapy. The most commonly used other medication was THP (38%).
Conclusion: The administration of adjuvant therapy with vitamins A, B, E, and folic acid can reduce the value of one or two of the five metabolic syndrome criteria for schizophrenia patients (p = 0.052) compared to the group of patients who did not receive vitamins A, B, E, and folic acid adjuvant therapy. Future research should use a longer duration to observe the effects of vitamins A, B, E, and folic acid and evaluate their therapeutic doses. Additionally, it should narrow down the criteria for medication use, focusing solely on the atypical antipsychotic’s clozapine or olanzapine.
References
SKI. Indonesian Health Survey. 2023;1–965.
Kurnia Utami I, Barliana MI, Halimah E. Cost Analysis of Antipsychotics Schizophrenia of Inpatients in Mental Hospital West Java Province. J Farm Galen (Galenika J Pharmacy). 2022;8(2):143–53.
Ardiansyah H, Azis U, Susanto HF, Limoa E. Pengaruh Penggunaan Obat Antipsikotik Atipikal terhadap Peningkatan Berat Badan dan Kadar Glukosa Darah Puasa Pasien Skizofrenia di Rumah Sakit Khusus Daerah Dadi Provinsi Sulawesi Selatan. 2024;8:10915–20.
Carli M, Kolachalam S, Longoni B, Pintaudi A, Baldini M, Aringhieri S, et al. Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences. Pharmaceuticals [Internet]. 2021 Mar 1 [cited 2024 Jul 16];14(3):238. Available from: /pmc/articles/PMC8001502/
Laursen TM. Life expectancy among persons with schizophrenia or bipolar affective disorder. Schizophr Res. 2011 Sep 1;131(1–3):101–4.
Annu, Baboota S, Ali J. Combination antipsychotics therapy for schizophrenia and related psychotic disorders interventions: Emergence to nanotechnology and herbal drugs. Vol. 61, Journal of Drug Delivery Science and Technology. Elsevier; 2021. p. 102272.
World Psychiatry - 2019 - Vancampfort - The impact of pharmacological and non?pharmacological interventions to improve.pdf.
Tharoor H, Maran S, Chandan AK, Pari M, Rao S, Durairaj J. Cognitive and negative symptoms in schizophrenia with L-Carnosine adjuvant therapy – A randomized double-blind placebo-controlled study. Pharmacol Res Perspect. 2023;11(2):1–8.
Chan MY, Qin Z, Man SC, Lam M, Lai WH, Ng RMK, et al. Adjunctive berberine reduces antipsychotic-associated weight gain and metabolic syndrome in patients with schizophrenia: a randomized controlled trial. Psychiatry Clin Neurosci [Internet]. 2022 Mar 1 [cited 2024 Oct 21];76(3):77–85. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/pcn.13323
Mujahid EH, Limoa E, Syamsuddin S, Bahar B, Renaldi R, Aminuddin A, et al. Effect of Probiotic Adjuvant Therapy on Improvement of Clinical Symptoms & Interleukin 6 Levels in Patients With Schizophrenia. Psychiatry Investig. 2022;19(11):898–908.
Lolobua MFIP, Khairina K, Wardani IAK, Santoso AMM. Negative Symptoms Management in Schizophrenia. J Psikiatri Surabaya [Internet]. 2021 May 31 [cited 2024 Aug 7];10(1):6–12. Available from: https://e-journal.unair.ac.id/JPS/article/view/20607
Putri WCC, Meray NW, Utami IW. Pengaruh Pemberian Minyak Ikan terhadap Hasil Terapi Pasien Skizofrenia Rawat Inap Berdasarkan Skala PANSS The Effect of Fish Oil Administration on the Therapeutic Outcome of Schizophrenic Inpatients Based on the PANSS Scale. J Sains Kes. 2021;3(6):795.
Suprapti R, Fitrikasari A, Pudjo R, Asikin HG, Noerhidajati E. Pengaruh Pemberian Ajuvan Asam Folat Terhadap Fungsi Personal Dan Sosial Pasien Skizofrenia Kronik. J Nutr Coll. 2021;10(3):243–50.
Lam NSK, Long XX, Li X, Saad M, Lim F, Doery JC, et al. The potential use of folate and its derivatives in treating psychiatric disorders: A systematic review. Biomed Pharmacother [Internet]. 2022;146:112541. Available from: https://doi.org/10.1016/j.biopha.2021.112541
Dewi R, Dinda A, Adinda R. RASIONALITAS PENGGUNAAN ANTIPSIKOTIK PADA PASIEN SKIZOFRENIA DI RUMAH SAKIT JIWA DAERAH PROVINSI JAMBI PERIODE APRIL – MEI 2022 RATIONALITY OF ANTIPSYCHOTIC USE IN SCHIZOPHRENIA PATIENT AT REGIONAL MENTAL HOSPITAL OF JAMBI PROVINCE ON APRIL – MARCH 2022 P. 2024;23(2).
Mens Health Foundation. Men and mental health | Mental Health Foundation [Internet]. Men and mental health. 2021 [cited 2024 Aug 5]. p. 1. Available from: https://www.mentalhealth.org.uk/explore-mental-health/a-z-topics/men-and-mental-health
Puig O, Fisher M, Loewy R, Miley K, Ramsay IS, Carter CS, et al. Early-versus adult-onset schizophrenia as a predictor of response to neuroscience-informed cognitive training. J Clin Psychiatry. 2020;81(2).
Moreno-Küstner B, Martín C, Pastor L. Prevalence of psychotic disorders and its association with methodological issues. A systematic review and meta-analyses. Vol. 13, PLoS ONE. Public Library of Science; 2018.
Agustaria Ginting. Karakteristik Penderita Skizofrenia Di Rumah Sakit Jiwa Prof.DR.M. Ris Ilmu Kesehat Umum. 2024;2(1).
Häfner H. From Onset and Prodromal Stage to a Life-Long Course of Schizophrenia and Its Symptom Dimensions: How Sex, Age, and Other Risk Factors Influence Incidence and Course of Illness. Psychiatry J. 2019;2019:1–15.
Sahni S, Chavan BS, Sidana A, Kalra P, Kaur G. Comparative study of clozapine versus risperidone in treatment-naive , first-episode schizophrenia : A pilot study. 2016;(November):697–703.
St?pnicki P, Kondej M, Kaczor AA. Current concepts and treatments of schizophrenia [Internet]. Vol. 23, Molecules. Multidisciplinary Digital Publishing Institute (MDPI); 2018 [cited 2024 Aug 2]. Available from: /pmc/articles/PMC6222385/
Araki E, Yamashita S, Arai H, Yokote K, Satoh J, Inoguchi T, et al. Effects of Pemafibrate, a Novel Selective PPAR? Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial. Diabetes Care [Internet]. 2018 Mar 1 [cited 2024 Oct 21];41(3):538–46. Available from: https://pubmed.ncbi.nlm.nih.gov/29298800/
Aringhieri S, Carli M, Kolachalam S, Verdesca V, Cini E, Rossi M, et al. Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences. Pharmacol Ther [Internet]. 2018 Dec 1 [cited 2024 Aug 7];192:20–41. Available from: https://pubmed.ncbi.nlm.nih.gov/29953902/
Utami VW, Darajati M, Puspitasari CE. Potensi interaksi obat pada pasien skizofrenia di Rumah Sakit Jiwa Mutiara Sukma tahun 2020. Sasambo J Pharm. 2022;3(1):36–42.
Riawan H, Kristanto CS, Ikawati Z. Perbandingan Regimen Terapi Antipsikotik Berbasis Risperidon Terhadap Sindrom Ekstrapiramidal, Fungsi Kognitif, dan Gangguan Metabolik Pada Pasien Schizophrenia. Maj Farm. 2022;18(2):162–71.
Sachdeva V, Ashraf S, Inam S, Shah K, Singla A, Mansuri Z, et al. Olanzapine-Induced Bradycardia [Internet]. Vol. 25, Primary Care Companion for CNS Disorders. Physicians Postgraduate Press, Inc.; 2023 [cited 2024 Aug 2]. p. 48464. Available from: https://www.psychiatrist.com/pcc/olanzapine-induced-bradycardia
Ashok T, Puttam H, Tarnate VCA, Jhaveri S, Avanthika C, Trejo Treviño AG, et al. Role of Vitamin B12 and Folate in Metabolic Syndrome. Cureus. 2021;13(10).
Li M, Li S, Chavarro JE, Gaskins AJ, Ley SH, Hinkle SN, et al. Prepregnancy habitual intakes of total, supplemental, and food folate and risk of gestational diabetes mellitus: A prospective cohort study. Diabetes Care [Internet]. 2019 Jun 1 [cited 2024 Aug 7];42(6):1034–41. Available from: /pmc/articles/PMC6609948/
Karin A. Mack*, Ann Dellinger and BAW. ?????? HHS Public Access. Physiol Behav. 2017;176(12):139–48.
Zhu J, Chen C, Lu L, Yang K, Reis J, He K. Intakes of Folate, Vitamin B6, and Vitamin B12 in Relation to Diabetes Incidence Among American Young Adults: A 30-Year Follow-up Study. Diabetes Care [Internet]. 2020 Oct 1 [cited 2024 Aug 7];43(10):2426–34. Available from: https://pubmed.ncbi.nlm.nih.gov/32737139/
Celik SF, Celik E. Subclinical atherosclerosis and impaired cardiac autonomic control in pediatric patients with Vitamin B12 deficiency. Niger J Clin Pract [Internet]. 2018 Aug 1 [cited 2024 Aug 7];21(8):1012–6. Available from: https://pubmed.ncbi.nlm.nih.gov/30074003/
Bahmani F, Galougahi FR, Vahedpoor Z, Jamilian M, Mahmoodi S, Baghban R, et al. The effects of folic acid supplementation on recurrence and metabolic status in endometrial hyperplasia: A randomized, double-blind, placebo-controlled trial. Arch Iran Med [Internet]. 2018 [cited 2024 Aug 7];21(10):452–9. Available from: https://pubmed.ncbi.nlm.nih.gov/30415553/
Zhu J, Chen C, Lu L, Shikany JM, D’Alton ME, Kahe K. Folate, Vitamin B6, and Vitamin B12 Status in Association With Metabolic Syndrome Incidence. JAMA Netw Open [Internet]. 2023 Jan 3 [cited 2024 Aug 7];6(1):e2250621–e2250621. Available from: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2800209
Musdalifah W, Susanti R, Robiyanto. Evaluasi Penggunaan Obat Triheksifenidil Sebagai Terapi Adjuvan Pada Pasien Skizofrenia di Instalasi Rawat Inap Rumah Sakit Jiwa Daerah Sungai Bangkong Pontianak. J Mhs Farm Fak … [Internet]. 2019;4(1):1–12. Available from: https://jurnal.untan.ac.id/index.php/jmfarmasi/article/view/43955%0Ahttps://jurnal.untan.ac.id/index.php/jmfarmasi/article/viewFile/43955/75676587791
Wati H, Hidayati R, Rizky M. Pengaruh KombinasitAntipsikotikiTehadaptEfektSamping Sindromt Ekstrapiramidal PasientSkizofrenia Rawat Inap Rumah Sakit Jiwa Sambang Lihum Banjarbaru. 2024;08(01):78–86.
Copyright (c) 2024 Journal of Public Health and Pharmacy
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with Journal of Public Health and Pharmacy retain the copyright of their work. The journal applies a Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0), which grants the following rights:
-
Copyright Retention: Authors retain the copyright of their work, maintaining full control over their intellectual property without restrictions.
-
Right of First Publication: Authors grant the journal the right of first publication of their work. This ensures that the work is initially published and credited in Journal of Public Health and Pharmacy.
-
License to Share and Reuse: The work is licensed under CC BY-SA 4.0, allowing others to copy, distribute, remix, and build upon the work for any purpose, even commercially, as long as proper credit is given to the authors, and any new creations are licensed under the same terms.
